TP53 and neoplasm: An orally bioavailable small molecule selective inhibitor, MI-219, binds to MDM2 like in the case of Nutlins and blocks MDM2-p53 interaction, leading to induction of cell cycle arrest in both normal and tumor cells but selective apoptosis only in tumor cells (Shangary et al., 2008).